Clinical Value of Peripheral Blood microRNA Detection in Evaluation of SOX Regimen as Neoadjuvant Chemotherapy for Gastric Cancer

Journal of Clinical Laboratory Analysis - United States
doi 10.1002/jcla.22363
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Neoadjuvant Chemotherapy of Resectable Advanced Gastric Cancer

Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons)
2012English

Neoadjuvant Chemotherapy in the Combined Treatment of Gastric Cancer

Onkologiya. Zhurnal imeni P.A.Gertsena
2014English

Clinical Evaluation of Cisplatin Sensitivity of Germline Polymorphisms in Neoadjuvant Chemotherapy for Urothelial Cancer

Clinical Genitourinary Cancer
OncologyUrology
2016English

Pathological Complete Response After Neoadjuvant Chemotherapy With Trastuzumab-Containing Regimen in Gastric Cancer: A Case Report

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2010English

Preclinical Evaluation of Exemestane as a Novel Chemotherapy for Gastric Cancer

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2019English

Oral UFT (Uracil Plus Futrafur) for Neoadjuvant Chemotherapy of Gastric Cancer

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
1999English

The Clinical Value and Usage of Inflammatory and Nutritional Markers in Survival Prediction for Gastric Cancer Patients With Neoadjuvant Chemotherapy and D2 Lymphadenectomy

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2020English

Evaluation of Antiemetic Therapy in Different Cancer Chemotherapy Regimen

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
2012English

DNAzyme-based Probe for Circulating microRNA Detection in Peripheral Blood

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy